Individualization of calcium entry-blocker dosage for systemic hypertension.
The calcium entry blockers are used in a wide variety of clinical situations. Coexisting disease states, such as renal or hepatic dysfunction, may require individualized dosing of these agents. The physiologic changes associated with aging may also affect the pharmacokinetic properties of the drugs. If calcium entry blockers are used concurrently with other medications, dosage adjustment or selection of an alternative drug may be needed. Drug interactions between calcium entry blockers and cimetidine, digoxin and quinidine appear to be clinically significant. Individualized dosing in patients who have coexisting disease or who are using other medications is essential to achieve an adequate therapeutic response and avoid adverse effects. Considerations to attain an optimal response in such situations are presented.
D000328:Adult; D000367:Age Factors; D000368:Aged; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use*; D002648:Child; D002927:Cimetidine / Q000494:pharmacology; D048909:Diabetes Complications; D004077:Digoxin / Q000494:pharmacology; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007674:Kidney Diseases / Q000150:complications; D007700:Kinetics; D007774:Lactation; D008107:Liver Diseases / Q000150:complications; D008875:Middle Aged; D011247:Pregnancy; D011802:Quinidine / Q000494:pharmacology; D012907:Smoking
D002121:Calcium Channel Blockers; D004077:Digoxin; D002927:Cimetidine; D011802:Quinidine